April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
TSPAN12 Mutations in Familial Exudative Vitreoretinopathy Patients
Author Affiliations & Notes
  • Wendy A. Dailey
    Research Institute, William Beaumont Hospital, Royal Oak, Michigan
  • Antonio Tarasconi
    Research Institute, William Beaumont Hospital, Royal Oak, Michigan
  • Courtney Kauh
    Research Institute, William Beaumont Hospital, Royal Oak, Michigan
  • Sean Gappy
    Research Institute, William Beaumont Hospital, Royal Oak, Michigan
  • Kimberly A. Drenser
    William Beaumont Hosp, Associated Retinal Consultants, Royal Oak, Michigan
  • Footnotes
    Commercial Relationships  Wendy A. Dailey, None; Antonio Tarasconi, None; Courtney Kauh, None; Sean Gappy, None; Kimberly A. Drenser, None
  • Footnotes
    Support  Margaret Walters Research Grant
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2383. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Wendy A. Dailey, Antonio Tarasconi, Courtney Kauh, Sean Gappy, Kimberly A. Drenser; TSPAN12 Mutations in Familial Exudative Vitreoretinopathy Patients. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2383.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Recently, Tetraspanin12 (TSPAN12) mutations have been reported in patients with Familial Exudative Vitreoretinopathy (AdFEVR). In this study we screened the TSPAN12 gene of FEVR patients by direct sequencing.

Methods: : Primers were designed to screen all 7 coding exons and splice sites of the TSPAN12 gene. PCR Reactions were run using Beckman Dye Terminator Cycle Sequencing kits with subsequent detection on a Beckman CEQ8000. The number of patients evaluated were as follows; 100 (FEVR), 49 (Possible FEVR) and 50 (control). Patients with a diagnosis of Possible FEVR were designated FEVR or (PFVS/Norrie/IP/Coats) after clinical examination. DNA from patients with an unrelated retinal disease, X-linked Retinoschisis (XLRS) was used as control.

Results: : A novel mutation in exon 6, (c.497delT), was discovered in a pair of brothers diagnosed with FEVR. No other sequence variations were found.

Conclusions: : Previous reports have indicated that ~10% of FEVR patients have TSPAN12 mutations. However very few studies have been conducted to date since TSPAN12 involvement in FEVR has been only recently discovered. In our study, we found that only 2% of the FEVR patients had TSPAN12 mutations. Perhaps this is an indication of the severity of disease within the patients of our study group. Since our practice is a referral center for pediatric retinal cases, the patient population tends to have more severe disease.

Keywords: gene screening 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×